Farallon Capital Management’s CVS Health CVS Stock Holding History

Farallon Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-694,259	Closed	-$64.7M	–	197
2022 Q4	$64.7M	Sell	694,259 -562,000	-45%	-$54.2M	0.38%	58
2022 Q3	$120M	Buy	1,256,259 +10,000	+0.8%	+$990K	0.66%	47
2022 Q2	$115M	Buy	1,246,259 +59,976	+5%	+$5.85M	0.63%	47
2022 Q1	$120M	Sell	1,186,283 -95,173	-7%	-$10M	0.58%	44
2021 Q4	$132M	Buy	1,281,456 +1,047,456	+448%	+$96.8M	0.66%	40
2021 Q3	$19.9M	Buy	+234,000	New	+$19.6M	0.09%	102
2020 Q1	–	Sell	-750,000	Closed	-$55.7M	–	106
2019 Q4	$55.7M	Sell	750,000 -150,000	-17%	-$10.5M	0.38%	53
2019 Q3	$56.8M	Buy	900,000 +77,500	+9%	+$4.59M	0.43%	47
2019 Q2	$44.8M	Buy	822,500 +197,500	+32%	+$10.6M	0.29%	58
2019 Q1	$33.7M	Sell	625,000 -305,000	-33%	-$18.8M	0.25%	60
2018 Q4	$60.9M	Buy	+930,000	New	+$69.4M	0.45%	43

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Farallon Capital Management's CVS Position: Q1 2023 in Review

Farallon Capital Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 694,259 shares — an estimated $64.7M sold.

Farallon Capital Management first reported a position in CVS in Q4 2018 and held it in 11 quarters. The position peaked at $132M in Q4 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Farallon Capital Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Farallon Capital Management sold 694,259 CVS Health shares in Q1 2023, an estimated $64.7M.
Farallon Capital Management first reported a position in CVS Health in Q4 2018 and held it in 11 quarters.
Farallon Capital Management's CVS Health position peaked at $132M in Q4 2021.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.